Literature DB >> 26740009

PI3Kδ promotes CD4(+) T-cell interactions with antigen-presenting cells by increasing LFA-1 binding to ICAM-1.

Fabien Garçon1, Klaus Okkenhaug1.   

Abstract

Activation of T lymphocytes by peptide/major histocompatibility complex on antigen-presenting cells (APCs) involves dynamic contacts between the two cells, during which T cells undergo marked morphological changes. These interactions are facilitated by integrins. Activation of the T cells increases the binding of the integrin lymphocyte function-associated antigen 1 (LFA-1) expressed by T cells to intercellular adhesion molecule (ICAM)-1 and ICAM-2 expressed by APCs. The signalling pathways that control integrin affinities are incompletely defined. The phosphoinositide 3-kinases (PI3Ks) generate second-messenger signalling molecules that control cell growth, proliferation, differentiation and trafficking. Here we show that in T cells, PI3Kδ attenuates the activation of Rac1, but sustains the activation of Rap1. Consequently, PI3Kδ increases LFA-1-dependent adhesion to form stable conjugates with APCs. Increased Rap1 activity and LFA-1 adhesion were only in part mediated by the downstream kinase Akt, suggesting the involvement of additional phosphatidylinositol(3,4,5)P3-binding proteins. These results establish a link between PI3K activity, cytoskeletal changes and integrin binding and help explain the impaired T-cell-dependent immune responses in PI3Kδ-deficient mice.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 26740009      PMCID: PMC4829101          DOI: 10.1038/icb.2016.1

Source DB:  PubMed          Journal:  Immunol Cell Biol        ISSN: 0818-9641            Impact factor:   5.126


  62 in total

1.  P-Rex1, a PtdIns(3,4,5)P3- and Gbetagamma-regulated guanine-nucleotide exchange factor for Rac.

Authors:  Heidi C E Welch; W John Coadwell; Christian D Ellson; G John Ferguson; Simon R Andrews; Hediye Erdjument-Bromage; Paul Tempst; Phillip T Hawkins; Len R Stephens
Journal:  Cell       Date:  2002-03-22       Impact factor: 41.582

2.  Essential role of phosphoinositide 3-kinase delta in neutrophil directional movement.

Authors:  Chanchal Sadhu; Boris Masinovsky; Ken Dick; C Gregory Sowell; Donald E Staunton
Journal:  J Immunol       Date:  2003-03-01       Impact factor: 5.422

3.  T-cell priming by dendritic cells in lymph nodes occurs in three distinct phases.

Authors:  Thorsten R Mempel; Sarah E Henrickson; Ulrich H Von Andrian
Journal:  Nature       Date:  2004-01-08       Impact factor: 49.962

Review 4.  Membrane-cytoskeleton interactions during the formation of the immunological synapse and subsequent T-cell activation.

Authors:  Vincent Das; Béatrice Nal; Anne Roumier; Vannary Meas-Yedid; Christophe Zimmer; Jean-Christophe Olivo-Marin; Pascal Roux; Pierre Ferrier; Alice Dautry-Varsat; Andrés Alcover
Journal:  Immunol Rev       Date:  2002-11       Impact factor: 12.988

5.  DOCK2 is essential for antigen-induced translocation of TCR and lipid rafts, but not PKC-theta and LFA-1, in T cells.

Authors:  Terukazu Sanui; Ayumi Inayoshi; Mayuko Noda; Eiko Iwata; Masahiro Oike; Takehiko Sasazuki; Yoshinori Fukui
Journal:  Immunity       Date:  2003-07       Impact factor: 31.745

6.  Chemokines trigger immediate beta2 integrin affinity and mobility changes: differential regulation and roles in lymphocyte arrest under flow.

Authors:  G Constantin; M Majeed; C Giagulli; L Piccio; J Y Kim; E C Butcher; C Laudanna
Journal:  Immunity       Date:  2000-12       Impact factor: 31.745

7.  Rap1 is a potent activation signal for leukocyte function-associated antigen 1 distinct from protein kinase C and phosphatidylinositol-3-OH kinase.

Authors:  K Katagiri; M Hattori; N Minato; S k Irie; K Takatsu; T Kinashi
Journal:  Mol Cell Biol       Date:  2000-03       Impact factor: 4.272

8.  Rap1A positively regulates T cells via integrin activation rather than inhibiting lymphocyte signaling.

Authors:  Eric Sebzda; Madelon Bracke; Tamara Tugal; Nancy Hogg; Doreen Ann Cantrell
Journal:  Nat Immunol       Date:  2002-02-11       Impact factor: 25.606

9.  Impaired B and T cell antigen receptor signaling in p110delta PI 3-kinase mutant mice.

Authors:  Klaus Okkenhaug; Antonio Bilancio; Géraldine Farjot; Helen Priddle; Sara Sancho; Emma Peskett; Wayne Pearce; Stephen E Meek; Ashreena Salpekar; Michael D Waterfield; Andrew J H Smith; Bart Vanhaesebroeck
Journal:  Science       Date:  2002-07-18       Impact factor: 47.728

10.  Phosphoinositide 3-kinase-mediated activation of cofilin phosphatase Slingshot and its role for insulin-induced membrane protrusion.

Authors:  Michiru Nishita; Yan Wang; Chinatsu Tomizawa; Akira Suzuki; Ryusuke Niwa; Tadashi Uemura; Kensaku Mizuno
Journal:  J Biol Chem       Date:  2003-11-26       Impact factor: 5.157

View more
  10 in total

1.  Integrin crosstalk allows CD4+ T lymphocytes to continue migrating in the upstream direction after flow.

Authors:  Sarah Hyun Ji Kim; Daniel A Hammer
Journal:  Integr Biol (Camb)       Date:  2019-12-31       Impact factor: 2.192

Review 2.  Phosphoinositide 3-kinase δ is a regulatory T-cell target in cancer immunotherapy.

Authors:  Ee Lyn Lim; Klaus Okkenhaug
Journal:  Immunology       Date:  2019-07       Impact factor: 7.397

Review 3.  Emerging role of BCR signaling inhibitors in immunomodulation of chronic lymphocytic leukemia.

Authors:  Kamira Maharaj; Eva Sahakian; Javier Pinilla-Ibarz
Journal:  Blood Adv       Date:  2017-09-26

4.  Combined BTK and PI3Kδ Inhibition with Acalabrutinib and ACP-319 Improves Survival and Tumor Control in CLL Mouse Model.

Authors:  Carsten U Niemann; Helena I Mora-Jensen; Eman L Dadashian; Fanny Krantz; Todd Covey; Shih-Shih Chen; Nicholas Chiorazzi; Raquel Izumi; Roger Ulrich; Brian J Lannutti; Adrian Wiestner; Sarah E M Herman
Journal:  Clin Cancer Res       Date:  2017-06-23       Impact factor: 12.531

5.  Asymmetric PI3K Activity in Lymphocytes Organized by a PI3K-Mediated Polarity Pathway.

Authors:  Yen-Hua Chen; Radomir Kratchmarov; Wen-Hsuan W Lin; Nyanza J Rothman; Bonnie Yen; William C Adams; Simone A Nish; Jeffrey C Rathmell; Steven L Reiner
Journal:  Cell Rep       Date:  2018-01-28       Impact factor: 9.423

Review 6.  RhoA as a Key Regulator of Innate and Adaptive Immunity.

Authors:  Matthias Bros; Katharina Haas; Lorna Moll; Stephan Grabbe
Journal:  Cells       Date:  2019-07-17       Impact factor: 6.600

7.  Enriched circulating and tumor-resident TGF-β+ regulatory B cells in patients with melanoma promote FOXP3+ Tregs.

Authors:  Robert J Harris; Zena Willsmore; Roman Laddach; Silvia Crescioli; Jitesh Chauhan; Anthony Cheung; Anna Black; Jenny L C Geh; Alastair D MacKenzie Ross; Ciaran Healy; Sophia Tsoka; James Spicer; Katie E Lacy; Sophia N Karagiannis
Journal:  Oncoimmunology       Date:  2022-07-28       Impact factor: 7.723

Review 8.  LFA-1 in T Cell Migration and Differentiation.

Authors:  Brandon L Walling; Minsoo Kim
Journal:  Front Immunol       Date:  2018-05-03       Impact factor: 7.561

Review 9.  β2 Integrins-Multi-Functional Leukocyte Receptors in Health and Disease.

Authors:  Monika Bednarczyk; Henner Stege; Stephan Grabbe; Matthias Bros
Journal:  Int J Mol Sci       Date:  2020-02-19       Impact factor: 5.923

Review 10.  PI3K in T Cell Adhesion and Trafficking.

Authors:  Kristoffer H Johansen; Dominic P Golec; Julie H Thomsen; Pamela L Schwartzberg; Klaus Okkenhaug
Journal:  Front Immunol       Date:  2021-08-06       Impact factor: 7.561

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.